hERG Inhibitors with Similar Potency But Different Binding Kinetics Do Not Pose the Same Proarrhythmic Risk: Implications for Drug Safety Assessment.
DI VEROLI, GIOVANNI Y. Ph.D. 1, 2; DAVIES, MARK R. Ph.D. 3; ZHANG, HENGGUI Ph.D. 4; ABI-GERGES, NAJAH Ph.D. 2; BOYETT, MARK R. Ph.D., F.R.C.P. 1
Journal of Cardiovascular Electrophysiology.
25(2):197-207, February 2014.
(Format: HTML, PDF)